• If you are wondering whether Molina Healthcare's current share price lines up with its underlying value, you are not alone. That is exactly what this article will unpack.
• Molina Healthcare's share price closed at US$144.47, with returns of 6.2% decline over 7 days, 18.9% decline over 30 days, 19.0% decline year to date, 55.9% decline over 1 year, 44.7% decline over 3 years, and 37.9% decline over 5 years that may have changed how some investors view its risk and potential.
• Recent news flow around Molina Healthcare has focused on its position in the US managed care space and ongoing scrutiny of healthcare costs and coverage policies, which can influence sentiment toward insurers like Molina. Investors have been weighing these headlines against the company’s role in government sponsored health plans and how policy discussions could affect future contracts and margins.
• On our valuation checklist, Molina Healthcare scores 5 out of 6 for being assessed as undervalued. Next we will compare what different valuation approaches say about the stock before finishing with a more holistic way to think about its fair value.

Approach 1: Molina Healthcare Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s dollars, aiming to estimate what the whole business might be worth right now.

For Molina Healthcare, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections in $. The latest twelve month free cash flow is a loss of $642.3 million, so the starting point is negative. Analysts provide early year estimates, and beyond that Simply Wall St extends those projections. This results in ten year free cash flow forecasts that move from a loss of $93 million in 2026 to $3,009.4 million in 2035.

Discounting these projected cash flows back to today gives an estimated intrinsic value of about $1,034.87 per share. Compared with the recent share price of $144.47, the model suggests the stock is about 86.0% undervalued under these assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Molina Healthcare is undervalued by 86.0%. Track this in your watchlist or portfolio, or discover 50 more high quality undervalued stocks.

Approach 2: Molina Healthcare Price vs Earnings

For profitable companies, the P/E ratio is a useful shorthand for how many dollars investors are currently paying for each dollar of earnings. This makes it a common way to compare businesses that already generate consistent profits.

What counts as a “normal” P/E often reflects two big things: how quickly earnings are expected to grow and how risky those earnings appear. Higher expected growth or lower perceived risk can justify a higher P/E, while slower growth or higher risk can point to a lower one.

Molina Healthcare currently trades on a P/E of 15.76x. That sits below the Healthcare industry average of about 22.36x and the peer group average of 22.50x. On simple comparisons, this can suggest the shares are priced more conservatively than many peers.

Simply Wall St also calculates a “Fair Ratio” of 26.15x for Molina Healthcare. This is a proprietary estimate of what the P/E might be given factors like earnings growth, profit margins, industry, market cap and key risks. Because it blends these company specific inputs rather than relying only on broad peer or industry averages, it can offer a more tailored benchmark.

Comparing the current P/E of 15.76x with the Fair Ratio of 26.15x points to the shares trading below that model based reference level.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Molina Healthcare Narrative

Earlier we mentioned that there is an even better way to understand valuation. On Simply Wall St’s Community page you can use Narratives, which let you attach your own story about Molina Healthcare to the numbers by linking your assumptions about future revenue, earnings and margins to a forecast and a fair value. You can then compare that fair value to today’s share price to help you decide whether you see the stock as priced attractively or not. Your view will update automatically when new news or earnings arrive. For example, one investor might build a more optimistic Molina Healthcare Narrative with a fair value around US$411.65, while another builds a more cautious one closer to US$144. Narratives give you a clear, side by side sense of how different perspectives on the same company translate into different valuations.

For Molina Healthcare, here are previews of two leading Molina Healthcare Narratives for you to review:

Fair value: US$411.65

Implied discount to this narrative: 64.9% compared to the last close of US$144.47

Revenue growth assumption: 7.42%

• Focuses on membership growth to about 5.7 million members, supported by new contract wins, acquisitions and expansion.
• Highlights premium revenue of roughly US$9.5b in Q1 2024 and expectations for full year 2024 premium revenue of about US$38b, with Medicare expansion and an active M&A and RFP pipeline as key drivers.
• Assumes revenue can reach beyond US$40b by 2027 with earnings growing annually, while flagging regulatory shifts, competition, medical cost control and Medicaid redeterminations as key risks.

Fair value: US$144.00

Implied premium to this narrative: 0.3% compared to the last close of US$144.47

Revenue growth assumption: 5.57%

• Frames rising medical costs, tighter government policies and reliance on large government contracts as ongoing sources of margin and earnings pressure, especially in Medicaid and Medicare.
• Builds in assumptions for revenue growth of 5.1% a year over 3 years, profit margins edging down, and a lower P/E multiple to match the more cautious analyst price targets, now centered around US$144.
• Points out that effective rate negotiations, operational efficiencies, acquisitions and wins like Florida CMS could still support earnings, but also notes analyst concern around Medicaid margin visibility and recent trims to earnings expectations.

If you find these contrasting fair values and assumptions useful, you can use them as starting points to form your own view on what Molina Healthcare is worth and which risks and drivers matter most to you.

Do you think there's more to the story for Molina Healthcare? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.